Release
📈 Stocks
Transpharmation Acquires OrganoTherapeutics to Expand Neuroscience CRO Reach
(just now)
Transpharmation Ltd. expands its global neuroscience CRO footprint through the strategic acquisition of OrganoTherapeutics, enhancing its preclinical research service offerings.